These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35727506)

  • 1. PD-1 Inhibitor-Induced Thyrotoxicosis Associated with Coronary Artery Spasm and Ventricular Tachycardia.
    Guo K; Chen M; Li J
    Cardiovasc Toxicol; 2022 Nov; 22(10-11):892-897. PubMed ID: 35727506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotoxicosis and coronary artery spasm: case report and review of the literature.
    Al Jaber J; Haque S; Noor H; Ibrahim B; Al Suwaidi J
    Angiology; 2010 Nov; 61(8):807-12. PubMed ID: 20498149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery spasm due to thyrotoxicosis.
    Common K; Milburn KS; Cawood TS; Crozier I
    N Z Med J; 2012 Jan; 126(1368):75-8. PubMed ID: 23385837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm.
    Sovari AA; Cesario D; Kocheril AG; Brugada R
    J Interv Card Electrophysiol; 2008 Apr; 21(3):223-6. PubMed ID: 18297382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol-induced coronary spasm in a patient with dilated cardiomyopathy associated with sustained ventricular tachycardia.
    Muto S; Ashizawa N; Arakawa S; Tanaka K; Komiya N; Toda G; Seto S; Yano K
    Intern Med; 2004 Nov; 43(11):1051-5. PubMed ID: 15609701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient ST-segment elevation due to iatrogenic hyperthyroidism in a patient with normal coronary arteries.
    Mustafa C; Ozgül U; Zehra GC; Hülya C
    Intern Med; 2011; 50(15):1595-7. PubMed ID: 21804288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variant (Prinzmetal's) angina with diffuse coronary spasm without coronary sclerosis].
    Willberg A; Lieb G; Nunberger D; Hochrein H
    Dtsch Med Wochenschr; 1990 Oct; 115(41):1549-52. PubMed ID: 2209443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index.
    Pollack R; Ashash A; Cahn A; Rottenberg Y; Stern H; Dresner-Pollak R
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32668461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasospastic angina in a patient with hyperthyroidism.
    Canpolat U; Sunman H; Gürses KM; Aytemir K
    Herz; 2012 Aug; 37(5):570-2. PubMed ID: 22407422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe coronary artery spasm during left atrial appendage closure plus catheter ablation for atrial fibrillation: case presentation.
    Xie X; Chen Z; Luo Y; Li X; Zhou J; Yu J; Yang B
    BMC Cardiovasc Disord; 2022 Feb; 22(1):38. PubMed ID: 35148671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
    Kotwal A; Kottschade L; Ryder M
    Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune checkpoint inhibitor-related thyroid dysfunction.
    Iwama S; Kobayashi T; Yasuda Y; Arima H
    Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101660. PubMed ID: 35501263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay Interference on Thyroid Function Tests During Treatment with Nivolumab.
    Paragliola RM; Corsello A; Papi G; Melfa E; Urbani A; Pontecorvi A; Corsello SM; Carrozza C
    Thyroid; 2020 Jul; 30(7):1091-1094. PubMed ID: 32122271
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasospastic angina in thyrotoxicosis--case reports.
    Nakano T; Konishi T; Takezawa H
    Angiology; 1987 Sep; 38(9):717-22. PubMed ID: 3662111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary arterial spasm in single coronary artery.
    Yamamoto K; Koiwaya Y; Tajimi T; Inou T; Mitsutake A; Orita Y; Takeshita A; Nakamura M
    Circulation; 1981 Dec; 64(6):1287-90. PubMed ID: 6794936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of ventricular tachycardia that was probably caused by coronary artery spasm induced by pericardial manipulation].
    Kimura H; Ogawa S; Koga Y; Mishima Y; Ushijima K
    Masui; 2014 Nov; 63(11):1272-5. PubMed ID: 25731063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
    Yamauchi I; Sakane Y; Fukuda Y; Fujii T; Taura D; Hirata M; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Sone M; Yasoda A; Inagaki N
    Thyroid; 2017 Jul; 27(7):894-901. PubMed ID: 28537531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.